Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone

Conditions:   Clinical Response;   Histopathological Response;   Prognosis Intervention:   Drug: first-line chemotherapy Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials